This year, I’m honored to support Team Rally for Sarc runners who have been selected to represent the Foundation for Sarcoidosis Research (FSR) at the 2025 TCS New York City Marathon on November 2, 2025!
This isn’t just a cause I care about — this is my life. My mom (BIG Steph) and sister (Brandy) are both living with sarcoidosis, and I’ve seen up close what it means to fight through the pain, the fatigue, and the unknowns that come with this disease. I’m also my mother’s primary caregiver, which gives me a front-row seat to the daily challenges and strength required to live with sarcoidosis. It’s what fuels me.
That’s why I said yes to something I never thought I’d do — run a marathon. Yes, this will be my very first marathon (cue the nerves and the energy gels!), but every step I take is for my mom, my sister, and the millions of others around the world facing sarcoidosis with resilience and hope.
On November 2nd, Team Rally for Sarc runners will take on 26.2 miles to raise awareness for sarcoidosis, support those impacted, and move us closer to a cure.
FSR is the leading international organization dedicated to finding a cure and improving care for sarcoidosis patients through research, education, and support. Since 2000, they’ve helped fuel over $8 million in sarcoidosis-specific research.
Sarcoidosis affects about 1.2 million people globally, including 200,000 in the U.S. It often comes with unpredictable and debilitating symptoms — extreme fatigue, difficulty breathing, chest pain, joint aches, skin issues, and more — with no known cause and limited treatment options.
I’m running this race to bring visibility to this rare disease and to make a difference for people like my mom and sister. I hope you’ll consider supporting me and Team Rally for Sarc with a donation. No amount is too small. Your gift will fund critical research, expand patient support, and bring us closer to a cure.
Thank you so much for being part of this journey with me.
Click here to learn more about sarcoidosis and the Foundation for Sarcoidosis Research.
Comments